Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 209

    1.

    Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients.

    Donato MF, Galmozzi E, Rigamonti C, Aghemo A.

    J Hepatol. 2012 Jun;56(6):1422. Epub 2012 Jan 28. No abstract available.

    PMID:
    22286002
    [PubMed - in process]
    2.

    Molecular epidemiology in HCV-related hepatocellular carcinoma: First steps.

    Villanueva A, Forns X, Llovet JM.

    J Hepatol. 2012 Jan 25. [Epub ahead of print] No abstract available.

    PMID:
    22282033
    [PubMed - as supplied by publisher]
    3.

    A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C.

    Thu Thuy PT, Bunchorntavakul C, Tan Dat H, Rajender Reddy K.

    J Hepatol. 2012 May;56(5):1012-8. Epub 2012 Jan 17.

    PMID:
    22266603
    [PubMed - in process]
    4.

    Understanding silibinin's modes of action against HCV using viral kinetic modeling.

    Guedj J, Dahari H, Pohl RT, Ferenci P, Perelson AS.

    J Hepatol. 2012 May;56(5):1019-24. Epub 2012 Jan 13.

    PMID:
    22245888
    [PubMed - in process]
    5.

    Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients.

    Valenti L, Aghemo A, Stättermayer AF.

    J Hepatol. 2012 May;56(5):1209-10; author reply 1210-2. Epub 2012 Jan 8. No abstract available.

    PMID:
    22230871
    [PubMed - in process]
    6.

    Error occurred: cannot get document summary

    PMID:
    22230870

    7.

    A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration.

    Wilson GK, Brimacombe CL, Rowe IA, Reynolds GM, Fletcher NF, Stamataki Z, Bhogal RH, Simões ML, Ashcroft M, Afford SC, Mitry RR, Dhawan A, Mee CJ, Hübscher SG, Balfe P, McKeating JA.

    J Hepatol. 2012 Apr;56(4):803-9. Epub 2011 Dec 16.

    PMID:
    22178269
    [PubMed - in process]
    Free PMC Article
    8.

    Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.

    Salmon D, Bani-Sadr F, Loko MA, Stitou H, Gervais A, Durant J, Rosenthal E, Quertainmont Y, Barange K, Vittecoq D, Shoai-Tehrani M, Alvarez M, Winnock M, Trinchet JC, Dabis F, Sogni P.

    J Hepatol. 2012 Apr;56(4):862-8. Epub 2011 Dec 13.

    PMID:
    22173166
    [PubMed - in process]
    9.

    13C-aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C.

    Rocco A, de Nucci G, Valente G, Compare D, D'Arienzo A, Cimino L, Perri F, Nardone G.

    J Hepatol. 2012 Apr;56(4):782-7. Epub 2011 Dec 13.

    PMID:
    22173159
    [PubMed - in process]
    10.

    Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load.

    Neukam K, Camacho A, Caruz A, Rallón N, Torres-Cornejo A, Rockstroh JK, Macías J, Rivero A, Benito JM, López-Cortés LF, Nattermann J, Gómez-Mateos J, Soriano V, Pineda JA.

    J Hepatol. 2012 Apr;56(4):788-94. Epub 2011 Dec 13.

    PMID:
    22173157
    [PubMed - in process]
    11.

    The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients.

    Nischalke HD, Berger C, Luda C, Müller T, Berg T, Coenen M, Krämer B, Körner C, Trebicka J, Grünhage F, Lammert F, Nattermann J, Sauerbruch T, Spengler U.

    J Hepatol. 2012 Apr;56(4):758-64. Epub 2011 Dec 13.

    PMID:
    22173151
    [PubMed - in process]
    12.

    Error occurred: cannot get document summary

    PMID:
    22100033

    13.

    Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C.

    Valenti L, Colombo M, Fargion S.

    J Hepatol. 2011 Dec;55(6):1470-1; author reply 1471-2. No abstract available.

    PMID:
    22100032
    [PubMed - indexed for MEDLINE]
    14.

    Hepatitis C treatment--clearing the mind.

    Forton DM.

    J Hepatol. 2012 Mar;56(3):513-4. Epub 2011 Nov 22. No abstract available.

    PMID:
    22115889
    [PubMed - in process]
    15.

    Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1.

    Howell CD, Gorden A, Ryan KA, Thompson AJ, Ibrahim C, Fried M, Afdhal NH, McHutchison JG, Shianna KV, Goldstein DB, Shuldiner AR, Mitchell BD.

    J Hepatol. 2012 Mar;56(3):557-63. Epub 2011 Oct 23.

    PMID:
    22027585
    [PubMed - in process]
    16.

    Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.

    Byrnes V, Miller A, Lowry D, Hill E, Weinstein C, Alsop D, Lenkinski R, Afdhal NH.

    J Hepatol. 2012 Mar;56(3):549-56. Epub 2011 Oct 23.

    PMID:
    22027578
    [PubMed - in process]
    17.

    Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C.

    Kurosaki M, Hiramatsu N, Sakamoto M, Suzuki Y, Iwasaki M, Tamori A, Matsuura K, Kakinuma S, Sugauchi F, Sakamoto N, Nakagawa M, Izumi N.

    J Hepatol. 2012 Mar;56(3):602-8. Epub 2011 Oct 23.

    PMID:
    22027574
    [PubMed - in process]
    18.

    Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.

    Soga T, Sugimoto M, Honma M, Mori M, Igarashi K, Kashikura K, Ikeda S, Hirayama A, Yamamoto T, Yoshida H, Otsuka M, Tsuji S, Yatomi Y, Sakuragawa T, Watanabe H, Nihei K, Saito T, Kawata S, Suzuki H, Tomita M, Suematsu M.

    J Hepatol. 2011 Oct;55(4):896-905. Epub 2011 Feb 18.

    PMID:
    21334394
    [PubMed - indexed for MEDLINE]
    19.

    Immunosuppression and HCV recurrence after liver transplantation.

    Samonakis DN, Germani G, Burroughs AK.

    J Hepatol. 2012 Apr;56(4):973-83. Epub 2011 Sep 29.

    PMID:
    21963518
    [PubMed - in process]
    20.

    Genomic risk of hepatitis C-related hepatocellular carcinoma.

    Hoshida Y, Fuchs BC, Tanabe KK.

    J Hepatol. 2012 Mar;56(3):729-30. Epub 2011 Sep 29. No abstract available.

    PMID:
    21963516
    [PubMed - in process]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk